IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 109 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,305,000 | -13.4% | 950,000 | 0.0% | 0.76% | -15.3% |
| Q2 2023 | $56,962,000 | +21.3% | 950,000 | 0.0% | 0.90% | +64.5% |
| Q1 2023 | $46,968,000 | -13.4% | 950,000 | 0.0% | 0.55% | -24.0% |
| Q4 2022 | $54,216,500 | +21.6% | 950,000 | 0.0% | 0.72% | +36.8% |
| Q3 2022 | $44,593,000 | +25.8% | 950,000 | 0.0% | 0.52% | +13.4% |
| Q2 2022 | $35,445,000 | +24.8% | 950,000 | 0.0% | 0.46% | +78.1% |
| Q1 2022 | $28,405,000 | -12.7% | 950,000 | 0.0% | 0.26% | +3.6% |
| Q4 2021 | $32,528,000 | -7.6% | 950,000 | 0.0% | 0.25% | +21.8% |
| Q3 2021 | $35,217,000 | -5.1% | 950,000 | 0.0% | 0.21% | -21.4% |
| Q2 2021 | $37,098,000 | -8.3% | 950,000 | 0.0% | 0.26% | -44.7% |
| Q1 2021 | $40,442,000 | – | 950,000 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |